Remedios Otero Candelera-rekin lankidetzan egindako argitalpenak (7)

2018

  1. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

    British Journal of Cancer, Vol. 119, Núm. 8, pp. 915-921

  2. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism

    Clinical and Applied Thrombosis/Hemostasis, Vol. 24, Núm. 3, pp. 489-495

  3. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism

    PLoS ONE, Vol. 13, Núm. 3

2017

  1. Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up

    Thrombosis Research

  2. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  3. Response

    Chest

  4. Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study

    Thrombosis Research, Vol. 157, pp. 90-96